Compare Modine Manufacturing Company (MOD) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Modine Manufacturing Company vs Philip Morris International Inc. — how do they compare? Modine Manufacturing Company trades at $181.56 (market cap $9.66B), while Philip Morris International Inc. trades at $201.19 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 32.3× Modine Manufacturing Company's market cap, and Philip Morris International Inc. pays a 3.19% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals — on Pluang, investors hold Modine Manufacturing Company for 33 Days and Philip Morris International Inc. for 85 Days on average.
| MOD | PM | |
|---|---|---|
Market Cap | $9.66B | $312.50B |
Volume | 1,331,946 | 5,517,172 |
Sector | Industrials | Consumer Staples |
52-Week High | $283.95 | $201.19 |
52-Week Low | $110.73 | $144.33 |
Typical Hold Time | 33 Days | 85 Days |
Enterprise Value | $10.09B | $355.62B |
Dividend Yield | — | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Modine Manufacturing (MOD) trades at $181.89, down 3.99% today amid a bearish technical signal, though it remains above key support at $177. The company recently completed a $946M spin-off of its Performance Technologies unit, a major corporate restructuring. Fundamentals show strong revenue growth to $3.4B in 2026 but declining net margins to 4.27%. Analysts maintain a bullish consensus with a $331.25 price target, citing momentum and growth potential despite near-term volatility.
Outlook: MOD offers growth exposure with analyst optimism but faces execution risks post-spin-off and margin pressure. The stock's high P/E of 67.87 suggests premium valuation, requiring sustained earnings beats to justify upside. Key risks include integration challenges and competitive pressures in thermal management markets.
Philip Morris International (PM) trades at $200.5, up 4.05% on the day, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations, and revenue growth is robust, driven by smoke-free products like IQOS and ZYN. The stock is near its pivot point of $200, with support at $197 and resistance at $203. Cash flow trends show improving operational performance, though debt levels remain elevated.
The outlook is positive due to earnings momentum and smoke-free product expansion, but risks include regulatory pressures and high valuation. Wall Street consensus is bullish with a $212.17 price target, suggesting upside potential. Investors should weigh growth prospects against macroeconomic and industry-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
